A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results

David A. Wohl; Calvin Cohen; Joel E. Gallant; Anthony Mills; Paul E. Sax; Edwin Dejesus; Andrew Zolopa; Hui C. Liu; Andrew Plummer; Kirsten L. White; Andrew K. Cheng; Martin S. Rhee; Javier Szwarcberg

doi:10.1097/QAI.0000000000000057

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results

David A. Wohl, Calvin Cohen, Joel E. Gallant, Anthony Mills, Paul E. Sax, Edwin Dejesus, Andrew Zolopa, Hui C. Liu, Andrew Plummer, Kirsten L. White, Andrew K. Cheng, Martin S. Rhee, Javier Szwarcberg

Research output: Contribution to journal › Article › peer-review

88 Scopus citations

Original language	English (US)
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	65
Issue number	3
DOIs	https://doi.org/10.1097/QAI.0000000000000057
State	Published - Mar 1 2014
Externally published	Yes

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

Access to Document

10.1097/QAI.0000000000000057

Cite this

Wohl, D. A., Cohen, C., Gallant, J. E., Mills, A., Sax, P. E., Dejesus, E., Zolopa, A., Liu, H. C., Plummer, A., White, K. L., Cheng, A. K., Rhee, M. S., & Szwarcberg, J. (2014). A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results. Journal of Acquired Immune Deficiency Syndromes, 65(3). https://doi.org/10.1097/QAI.0000000000000057

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results. / Wohl, David A.; Cohen, Calvin; Gallant, Joel E. et al.
In: Journal of Acquired Immune Deficiency Syndromes, Vol. 65, No. 3, 01.03.2014.

Research output: Contribution to journal › Article › peer-review

Wohl, DA, Cohen, C, Gallant, JE, Mills, A, Sax, PE, Dejesus, E, Zolopa, A, Liu, HC, Plummer, A, White, KL, Cheng, AK, Rhee, MS & Szwarcberg, J 2014, 'A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results', Journal of Acquired Immune Deficiency Syndromes, vol. 65, no. 3. https://doi.org/10.1097/QAI.0000000000000057

Wohl DA, Cohen C, Gallant JE, Mills A, Sax PE, Dejesus E et al. A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results. Journal of Acquired Immune Deficiency Syndromes. 2014 Mar 1;65(3). doi: 10.1097/QAI.0000000000000057

Wohl, David A. ; Cohen, Calvin ; Gallant, Joel E. et al. / A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection : Analysis of Week 144 Results. In: Journal of Acquired Immune Deficiency Syndromes. 2014 ; Vol. 65, No. 3.

@article{0f444c64e7b94266a581979aeb73297c,

title = "A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results",

author = "Wohl, {David A.} and Calvin Cohen and Gallant, {Joel E.} and Anthony Mills and Sax, {Paul E.} and Edwin Dejesus and Andrew Zolopa and Liu, {Hui C.} and Andrew Plummer and White, {Kirsten L.} and Cheng, {Andrew K.} and Rhee, {Martin S.} and Javier Szwarcberg",

year = "2014",

month = mar,

day = "1",

doi = "10.1097/QAI.0000000000000057",

language = "English (US)",

volume = "65",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection

T2 - Analysis of Week 144 Results

AU - Wohl, David A.

AU - Cohen, Calvin

AU - Gallant, Joel E.

AU - Mills, Anthony

AU - Sax, Paul E.

AU - Dejesus, Edwin

AU - Zolopa, Andrew

AU - Liu, Hui C.

AU - Plummer, Andrew

AU - White, Kirsten L.

AU - Cheng, Andrew K.

AU - Rhee, Martin S.

AU - Szwarcberg, Javier

PY - 2014/3/1

Y1 - 2014/3/1

UR - http://www.scopus.com/inward/record.url?scp=84894503546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894503546&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000000057

DO - 10.1097/QAI.0000000000000057

M3 - Article

C2 - 24256630

AN - SCOPUS:84894503546

SN - 1525-4135

VL - 65

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 3

ER -

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this